We then expanded this analysis to additional targets including cystatin 6 (CST6), a cysteine protease inhibitor which functions as a tumor suppressor and has been identified as a repression target of TBX2 through a mechanism involving EGR1 [24]. This evidence concerns the gene EGR1 and neoplasm.